Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia.

Paats MS, Bergen IM, Hanselaar WE, Groeninx van Zoelen EC, Hoogsteden HC, Hendriks RW, van der Eerden MM.

Eur Respir J. 2013 Jun;41(6):1378-85. doi: 10.1183/09031936.00060112. Epub 2012 Dec 20.

2.

Expression of pro-inflammatory cytokines by flow-sorted alveolar macrophages in severe pneumonia.

Maus U, Rosseau S, Knies U, Seeger W, Lohmeyer J.

Eur Respir J. 1998 Mar;11(3):534-41.

3.

Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.

Lee YL, Chen W, Chen LY, Chen CH, Lin YC, Liang SJ, Shih CM.

J Crit Care. 2010 Mar;25(1):176.e7-13. doi: 10.1016/j.jcrc.2009.05.002. Epub 2009 Jul 9.

PMID:
19592208
4.

T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia.

Paats MS, Bergen IM, Hanselaar WE, van Zoelen EC, Verbrugh HA, Hoogsteden HC, van den Blink B, Hendriks RW, van der Eerden MM.

Thorax. 2013 May;68(5):468-74. doi: 10.1136/thoraxjnl-2012-202168. Epub 2013 Jan 12.

PMID:
23315492
5.

Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.

Antunes G, Evans SA, Lordan JL, Frew AJ.

Eur Respir J. 2002 Oct;20(4):990-5.

6.

Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.

Montón C, Torres A, El-Ebiary M, Filella X, Xaubet A, de la Bellacasa JP.

Crit Care Med. 1999 Sep;27(9):1745-53.

PMID:
10507593
7.

Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia.

Moret I, Lorenzo MJ, Sarria B, Cases E, Morcillo E, Perpiñá M, Molina JM, Menéndez R.

Eur Respir J. 2011 Nov;38(5):1158-64. doi: 10.1183/09031936.00190410. Epub 2011 Mar 24.

8.

Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?

Kelly E, MacRedmond RE, Cullen G, Greene CM, McElvaney NG, O'Neill SJ.

Respirology. 2009 Mar;14(2):210-6. doi: 10.1111/j.1440-1843.2008.01423.x.

PMID:
19272082
9.

Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.

Wu HP, Chen CK, Chung K, Jiang BY, Yu TJ, Chuang DY.

J Formos Med Assoc. 2009 Jan;108(1):20-7. doi: 10.1016/S0929-6646(09)60028-0.

10.

Systemic cytokine profile in children with community-acquired pneumonia.

Michelow IC, Katz K, McCracken GH, Hardy RD.

Pediatr Pulmonol. 2007 Jul;42(7):640-5.

PMID:
17534977
11.

Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.

Schütte H, Lohmeyer J, Rosseau S, Ziegler S, Siebert C, Kielisch H, Pralle H, Grimminger F, Morr H, Seeger W.

Eur Respir J. 1996 Sep;9(9):1858-67.

12.

Etiology and cytokine expression in patients requiring mechanical ventilation due to severe community-acquired pneumonia.

Wu CL, Chan MC, Chang GC, Lee YL, Chin CS, Chang KM, Hsu JY.

J Formos Med Assoc. 2006 Jan;105(1):49-55.

13.

Interleukin 6, lipopolysaccharide-binding protein and interleukin 10 in the prediction of risk and etiologic patterns in patients with community-acquired pneumonia: results from the German competence network CAPNETZ.

Zobel K, Martus P, Pletz MW, Ewig S, Prediger M, Welte T, Bühling F; CAPNETZ study group.

BMC Pulm Med. 2012 Feb 20;12:6. doi: 10.1186/1471-2466-12-6.

15.

Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia.

Fernandez-Botran R, Uriarte SM, Arnold FW, Rodriguez-Hernandez L, Rane MJ, Peyrani P, Wiemken T, Kelley R, Uppatla S, Cavallazzi R, Blasi F, Morlacchi L, Aliberti S, Jonsson C, Ramirez JA, Bordon J.

Inflammation. 2014 Aug;37(4):1158-66. doi: 10.1007/s10753-014-9840-2.

PMID:
24557760
16.

Plasma kallistatin levels in patients with severe community-acquired pneumonia.

Lin WC, Lu SL, Lin CF, Chen CW, Chao L, Chao J, Lin YS.

Crit Care. 2013 Feb 8;17(1):R27. doi: 10.1186/cc12507.

17.

Circulating interleukin 6 and interleukin 10 in community acquired pneumonia.

Glynn P, Coakley R, Kilgallen I, Murphy N, O'Neill S.

Thorax. 1999 Jan;54(1):51-5.

18.

Bronchoalveolar interleukin-1 beta: a marker of bacterial burden in mechanically ventilated patients with community-acquired pneumonia.

Wu CL, Lee YL, Chang KM, Chang GC, King SL, Chiang CD, Niederman MS.

Crit Care Med. 2003 Mar;31(3):812-7.

PMID:
12626989
19.

Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome.

Chien JY, Hsueh PR, Cheng WC, Yu CJ, Yang PC.

Respirology. 2006 Nov;11(6):715-22.

PMID:
17052299
20.

Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children.

Xu XF, Li XJ, Liu JL, Wu L, Chen ZM.

Cytokine. 2016 Oct;86:73-78. doi: 10.1016/j.cyto.2016.07.018. Epub 2016 Jul 29.

PMID:
27475111

Supplemental Content

Support Center